A case of treatment-refractory psychosis responsive to sertindole

Schizophrenia Research

Volumn 30, Issue 1, 1998, Pages 105-108

  Geracioti, Thomas D ^a,b   Parker, Sharon ^a   Lowther, Nola B ^a,b   Wortman, Matthew ^a,b   Richtand, Neil M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Antipsychotics (atypical); Schizophrenia (treatment); Sertindole

Indexed keywords

NEUROLEPTIC AGENT; SERTINDOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RECEPTOR BINDING; HOSPITALIZATION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; HUMANS; IMIDAZOLES; INDOLES; MALE; PSYCHOTIC DISORDERS; REFRACTORY PERIOD, PSYCHOLOGICAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032570755     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00127-8     Document Type: Article

References (9)

1. Casey, D.E., 1996. Behavioral effects of sertindole, risperidone, clozapine, and haloperidol in Cebus monkeys. Psychopharmacology 124, 134-140.
2. Didriksen, M., 1995. Effects of antipsychotics on cognitive behavior in rats using the delayed non-match to positon paradigm. Eur. J. Pharmacol. 281, 241-250.
3. 1 receptors (ex vivo radioreceptor binding studies). J. Neural Trans. 89, 61-69.
4. 2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol. Bull. 25, 390-392.
5. Rossi, A., Mancini, F., Stratta, P., Mattei, P., Gismondi, R., Pozzi, F., Casacchia, M., 1997. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study. Acta. Psychiatr. Scand. 95, 40-43.
6. Sanchez, C., Arnt, J., Dragsted, N., Hyttel, J., Lembol, H.L., Meier, E., Perregaard, J., Skarsfeldt, T., 1991. Neurochemical and in vivo pharmacologic profile of sertidole, a limbic-selective compound. Drug Dev. Res. 22, 239-250.
7. Skarsfeldt, T., Perregaard, J., 1990. Sertindole, a new neuroleptic with extereme selectivity on A10 versus A9 dopamine neurones in the rat. Eur. J. Pharmacol. 1982, 212-215.
8. Skarsfeldt, T., 1992. Electrophysiologic profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurons in rats: acute and repeated treatament. Synapse 10, 25-33.
9. van Kammen, D.P., McEvoy, J.P., Targum, S.D., Kardatzke, T., Sebree, T.B., Sertindole Study Group, 1996. A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology, 124, 168-175.